Showing the latest 10 filings. Sign in to filter or browse the full history.
Showing 10 of 29 filings.
20 Aug 20261 filing
Incremental EBPP allocation
- Coastal Biotech, a Coastal Corporation subsidiary, received incremental EBPP Ethanol allocation for ESY 2025-26.
- The allocation is 4,310 KL to supply to BPCL, IOCL, and HPCL under EBPP across locations.
8 Aug 20261 filing
Bank repayment-date clarification
- Context: clarification following a recent credit rating revision on repayments.
- Funds for scheduled repayments were available; bank records reflect processing dates.
- MTM/FCY movements and facility-level processing cause value-dating, not borrower delays.
- May 31, 2025: EMI recovery for Cash Credit/OD; no borrower delay.
- Dec 1, 2025: EMI recoveries for two loans completed; value-date Nov 30, 2025; no delay.
- Mar 2, 2026: EMI recoveries for two loans completed; value-date Feb 28, 2026; no delay.
- Apr 8, 2026 & May 7, 2026: recoveries completed after MTM/FCY delays; WC constraints resolved.
- Overall account conduct satisfactory; no stress observed in facilities.
7 Aug 20261 filing
Rating action
- Long-term bank facilities Rs 68.28 crore downgraded to CARE D from CARE BB.
- Long-term/short-term facilities Rs 273.50 crore downgraded to CARE D / CARE D.
Rated facilities
- Total facilities rated Rs 341.78 crore.
- Long-term bank facilities and fund-based limits comprise the above totals.
Rationale
- Downgrade due to FY26 operational and financial performance and delays in annual report.
- Possible impact on credit profile cited by CARE Ratings.
Outlook / Change since last rating
- Outlook not disclosed in action; prior rating had Stable outlook.
- Change since last rating: Downgraded from CARE BB; prior outlook Stable.
Agency
- Rating agency: CARE Ratings Limited (CareEdge Ratings).
Material changes
- Downgrade from CARE BB to CARE D for both instruments.
23 Jul 20261 filing
Meeting Details
- Date: 3 August 2026; time and venue not disclosed.
Key Agenda Items
- Un-Audited financial results for quarter ended 30 June 2026 to be considered.
Other Notes
- Trading window closed from 1 July 2025; reopens 48 hours after the board meeting.
7 Jul 20261 filing
Dematerialisation status
- No dematerialisation/rematerialisation requests were received during the reporting period.
29 Jun 20261 filing
Trading window
- Trading window closed from 1 July 2026 until 48 hours after results for quarter ended 30 June 2026.
16 Jun 20261 filing
Business
- Coastal Corporation processes and exports shrimp and value-added seafood products.
- It also operates a grain-based ethanol business through subsidiary Coastal Biotech.
Operations
- Seafood operations include Unit II and Unit III facilities in Andhra Pradesh.
- Ethanol plant capacity is 198 KLPD in Odisha.
Financials
- Seafood business revenue was Rs 728.75 crore, with EBITDA of Rs 35.31 crore.
- Seafood EBITDA margin was 4.85%; PBT was Rs 17.36 crore.
- Ethanol business revenue was Rs 241.90 crore, with EBITDA of Rs 25.16 crore.
- Ethanol EBITDA margin was 10.40%; PBT was Rs 17.49 crore.
Leadership
- Mr. G.V.V. Satyanarayana is Director-Finance and CFO.
- Dr. E. Sankara Rao is Chairman and Independent Director.
- Mr. Valsaraj Thottoli is Founder, Vice Chairman and Managing Director.